156 related articles for article (PubMed ID: 20128969)
1. [Analysis of the relationship between hepatorenal syndrome and plasma ammonia].
He Y; Li GX; Xia Y
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):45-8. PubMed ID: 20128969
[TBL] [Abstract][Full Text] [Related]
2. Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: a retrospective analysis.
Appenrodt B; Zielinski J; Brensing KA; Heller J; Sauerbruch T; Schepke M
Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1428-32. PubMed ID: 19794309
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide, ammonia, and CRP levels in cirrhotic patients with hepatic encephalopathy: is there a connection?
Papadopoulos N; Soultati A; Goritsas C; Lazaropoulou C; Achimastos A; Adamopoulos A; Dourakis SP
J Clin Gastroenterol; 2010; 44(10):713-9. PubMed ID: 20495469
[TBL] [Abstract][Full Text] [Related]
4. [Propranolol, hepatic encephalopathy and blood levels of ammonia in hepatic cirrhosis].
Errico M; Giacobbe A; Facciorusso D; Simone P; Conoscitore P; De Maio ; Spirito F
Minerva Dietol Gastroenterol; 1987; 33(3):223-6. PubMed ID: 3670672
[No Abstract] [Full Text] [Related]
5. [Role of zinc deficiency in development of hepatic encephalopathy in patients with liver cyrrosis].
Shaposhnikova NA
Eksp Klin Gastroenterol; 2007; (3):108-12. PubMed ID: 17937015
[No Abstract] [Full Text] [Related]
6. Serum sodium identifies patients with cirrhosis at high risk of hepatorenal syndrome.
Janičko M; Veselíny E; Abraldes JG; Jarčuška P
Z Gastroenterol; 2013 Jul; 51(7):628-34. PubMed ID: 23696114
[TBL] [Abstract][Full Text] [Related]
7. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
8. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
[TBL] [Abstract][Full Text] [Related]
9. [Changes in arterial blood ammonia levels in cirrhosis. Study during and after mannitol lavage in post-hemorrhagic hepatic encephalopathy].
Doffoel M; Kopferschmitt J; Coumaros D; Girard M; Bockel R
Nouv Presse Med; 1978 Sep; 7(29):2575. PubMed ID: 309107
[No Abstract] [Full Text] [Related]
10. Terlipressin in 30 patients with hepatorenal syndrome: results of a retrospective study.
von Kalckreuth V; Glowa F; Geibler M; Lohse AW; Denzer UW
Z Gastroenterol; 2009 Jan; 47(1):21-6. PubMed ID: 19156588
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
[TBL] [Abstract][Full Text] [Related]
12. Frequency of hepatorenal syndrome among cirrhotics.
Kumar R; Ahmed R; Rathi SK; Sethar GH
J Coll Physicians Surg Pak; 2005 Oct; 15(10):590-3. PubMed ID: 19810292
[TBL] [Abstract][Full Text] [Related]
13. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure.
Odeh M; Sabo E; Srugo I; Oliven A
Ann Med; 2005; 37(8):603-12. PubMed ID: 16338762
[TBL] [Abstract][Full Text] [Related]
14. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M
Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138
[TBL] [Abstract][Full Text] [Related]
15. Renal tubular acidosis in cirrhosis. A determinant of susceptibility to recurrent hepatic precoma.
Shear L; Bonkowsky HL; Gabuzda GJ
N Engl J Med; 1969 Jan; 280(1):1-7. PubMed ID: 5761704
[No Abstract] [Full Text] [Related]
16. [Complications of liver cirrhosis].
Appenrodt B; Trebicka J; Sauerbruch T
Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1601-4. PubMed ID: 21809252
[No Abstract] [Full Text] [Related]
17. [Cox regression analysis of predictive factors of hepatorenal syndrome].
Zhang WJ; Yang DH; Shu JC
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):586-7. PubMed ID: 14572331
[TBL] [Abstract][Full Text] [Related]
18. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of 38 patients with hepatorenal syndrome].
Wang Y; Cui Y; Jia JD; Ou XJ; Qian LX; Zhang FK; Yin SS; Zhao XY; Wang BE
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):628. PubMed ID: 14572349
[No Abstract] [Full Text] [Related]
20. Common complications of cirrhosis: do we follow too often the 'Casablanca strategy'?
Gundling F; Schmidt T; Schepp W
Liver Int; 2011 Nov; 31(10):1598-600. PubMed ID: 21745306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
